Skip to main content

Dogwood Therapeutics, Inc.

For the period ended Jun 16, 2026. Filed Apr 27, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 16, 2026 · Filed Apr 27, 2026

Use the contents to explore the available documents and sections.

DWTX$1.28+23.1%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

PROXY STATEMENT

ANNUAL MEETING OF STOCKHOLDERS

To Be Held June 16, 2026

IMPORTANT NOTICE REGARDING AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL STOCKHOLDER MEETING TO BE HELD ON TUESDAY, JUNE 16, 2026

Copies of this Proxy Statement, form of proxy card, and Annual Report on Form 10-K (the “Annual Report”), are available at https://ir.dwtx.com/events-presentations/meeting.

Your vote is important. Please vote in one of these ways:

1)BY INTERNET: Go to http://www.proxyvote.com and follow the instructions. You will need to enter the control number printed on your proxy card;
2)BY TELEPHONE: Call toll-free 1-800-690-6903 and follow the instructions. You will need to enter the control number printed on your proxy card;
3)IN WRITING: Complete, sign, date and promptly return your proxy card in the enclosed envelope; or
4)AT THE ANNUAL MEETING: Follow the instructions that will be available at https://edge.media-server.com/mmc/go/dwtx2026agm during the virtual Annual Meeting.

This Proxy Statement and the accompanying proxy card and Annual Report are intended to be sent or given to stockholders of Dogwood Therapeutics, Inc. (the “Company”, “Dogwood”, “we”, “us” or “our”) on or about April 28, 2026, in connection with the solicitation of proxies on behalf of our Board of Directors (our “Board”) for use at our 2026 Annual Meeting of Stockholders (the “Annual Meeting”), to be held virtually on Tuesday, June 16, 2026, at 10:00 a.m. Eastern Time, and at any adjournment or postponement thereof.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.